Dynamics of HBsAg clearance in a UK cohort of chronic HBV infection
Hepatitis B surface antigen (HBsAg) has recently gained traction as a biomarker that may provide prognostic information and inform treatment decisions in chronic hepatitis B virus (HBV) infection. It may be particularly useful when HBV DNA levels are low and therefore difficult to quantify accuratel...
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Conference item |
| Foilsithe / Cruthaithe: |
Elsevier
2018
|